Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer

NCT00617656 is registered in ClinicalTrials.gov with Spanish Lung Cancer Group as lead sponsor.

NCT NCT00617656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer
Lead sponsor
Spanish Lung Cancer Group
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2008
Completion date
April 30, 2015
Enrollment
382 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, non small cell lung cancer